VYGR Voyager Pharma: Market Capitalization

Public company logo of Voyager Therapeutics, Inc. (VYGR)

Voyager Therapeutics (VYGR) revenue is based on royalties and upfront payments from the licensing of gene correction methods for neuropathologies. Meanwhile, the business adheres to bioethical principles, minimizing the use of chemicals and guaranteeing the protection of patient data. Serving as an assessment tool, this chart of the valuation on GURU.Markets, where the indicator stands at 0.10, confirms the value of unique patents for brain drug delivery, which allow the company to collaborate effectively with global partners.

VYGR Voyager Therapeutics, Inc.: Market Value in the range 07/04/2022 - 11/17/2026

VYGR (Voyager Therapeutics, Inc.): analytical breakdowns and indicator data

Fundamental company analysis:VYGR (Voyager Pharma)
Product sample of voyagertherapeutics.com

The integration of ESG principles and bioethics into the development of gene therapies strengthens the market position of Voyager Therapeutics (VYGR). Market capitalization reflects the aggregate value of all the company's shares, calculated based on current quotes. This metric serves as an indicator of the market consensus regarding the business's value. Monitoring this figure allows investors to assess capital preservation over the long term. The price action in this company valuation chart helps identify shifts in the macroeconomic cycle in a timely manner.

Key competitors

Market Capitalization BIIB (Biogen Idec)|Neurocrine Biosciences Inc - Market Value|regencellbioscience.com - Market Capitalization|Market Capitalization axsome.com AXSM|ACAD: Market Capitalization|Market Value Xenon Pharmaceuticals Inc. (XENE)|Market Value Viking Therapeutics|Market Capitalization SUPN (Supernus Pharma)|Market Capitalization CPRX|DNLI - Market Value|harmonybiosciences.com - Market Valuation|Market Capitalization Biohaven Ltd BHVN|AMLX - Market Value|Market Value TRVI (Trevi Corp)|Praxis Precision Medicines Inc (PRAX) - Market Value|Market Value Anavex Life Sciences (AVXL)|CBLL (CeriBell Inc) - Market Capitalization|Prothena Corporation - Market Valuation|Market Value Alector (ALEC)|Annexon Biosciences Inc. - Market Capitalization|Market Capitalization OMER (Omeros)|Market Capitalization neurogene.com NGNE|AC Immune S.A. - Market Capitalization|Neumora (NMRA) - Market Valuation|SCLX: Market Capitalization|Market Capitalization Tevogen Bio Holdings, Inc. TVGN|Market Valuation ACOG|CGTX (Cognition Therapeutics, Inc.) - Market Value|Market Capitalization IKT|Market Capitalization Cassava (SAVA)|Market Value Assertio ASRT|Coya Therapeutics, Inc. (COYA) - Market Value|VTGN: Market Valuation|Market Value OVID (ovidrx.com)|ABOS: Market Capitalization|CRVO - Market Capitalization|ATHE (alteritytherapeutics.com) - Market Capitalization|Market Valuation clene.com (CLNN)|Market Value pepgen.com (PEPG)|JUNS (Jupiter Neurosciences, Inc.) - Market Value|Market Capitalization RLMD (relmada.com)|Market Capitalization Annovis Bio Inc (ANVS)|GRCE: Market Valuation|Market Capitalization Firefly Neuroscience Inc AIFF|KLTO: Market Capitalization|NeuroSense Therapeutics Ltd - Market Value|Market Valuation RVPH|Market Capitalization MTVA (MetaVia Inc)|Market Value NeurAxis Inc (NRXS)|Helius Medical Technologies Inc. - Market Capitalization|Market Capitalization PASG (Passage Bio Inc.)|Market Capitalization bionomics.com.au NEUP|Minerva Neurosciences Inc - Market Capitalization|ATHA - Market Capitalization|ADXN: Market Capitalization|Alzamend (ALZN) - Market Capitalization|CYCN (cyclerion.com) - Market Capitalization|Protagenic Therapeutics (PTIX) - Market Capitalization|Market Value pasitheaclinics.com (KTTA)|CRGT (Cortigent Inc) - Market Value|Market Capitalization ATXI (Avenue Therapeutics Inc)|Market Value BCLI|Cara Therapeutics Inc - Market Capitalization|Chromocell Therapeutics (CHRO) - Market Valuation|ELYM (Eliem Therapeutics Inc.) - Market Valuation|ITCI - Market Capitalization|Market Value Longboard Pharma|Market Capitalization MRNS (Marinus Pharma)|Market Value NKGen Biotech Inc (NKGN)|NRBO - Market Value|Market Capitalization SAGE (Sage Therapeutics Inc)|Synaptogenix Inc. (SNPX) - Market Value|TRVN: Market Valuation|Market Capitalization vigilneuro.com VIGL|WENA (Anew Medical Inc.) - Market Valuation|Market Valuation Cerevel Therapeutics